{
  "meta": {
    "title": "Aub_Endometriosis_And_Adenomyosis",
    "url": "https://brainandscalpel.vercel.app/aub-endometriosis-and-adenomyosis-28bd4169.html",
    "scrapedAt": "2025-11-30T08:49:35.752Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Sampson's theory - Retrograde menstruation</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Meyer & Ivanoff's theory - Coelomic metaplasia</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Halban's theory - Metastatic spread (lymphatic or hematogenous)</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following theories for genesis of endometriosis is wrongly matched with the pathophysiology behind it?</span></p>",
      "unique_key": "DT1289182",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289182,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em><u>The main theories of endometriosis:</u></em></strong></p>\r\n<p><strong>OPTION A: <em>Sampson's Theory (Retrograde Menstruation Theory)</em></strong></p>\r\n<ul>\r\n<li>Proposed by John A. Sampson, this theory suggests that endometrial cells flow backward through the fallopian tubes into the pelvic cavity during menstruation, where they implant and grow.</li>\r\n</ul>\r\n<p><strong>OPTION B: <em>Coelomic Metaplasia Theory (Meyer &amp; Ivanoff's Theory)</em></strong></p>\r\n<ul>\r\n<li>Proposed by Meyer &amp; Ivanoff, this theory suggests that cells lining the pelvic peritoneum, which are derived from the coelomic epithelium, can transform into endometrial tissue under certain conditions.</li>\r\n</ul>\r\n<p><strong>OPTION C: <em>Metastatic Spread Theory (Halban's Theory)</em></strong></p>\r\n<ul>\r\n<li>Proposed by Halban, this theory suggests that endometrial cells spread to distant locations via the lymphatic system or blood vessels, leading to ectopic endometrial tissue implantation.</li>\r\n</ul>\r\n<p>Hence, OPTION D is correct.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206f57395f5-8eb6-47ca-880b-67ef48c4368e.jpg\">",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Depth of penetration is more related to symptoms rather than the spread</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Midline lesions are more symptom producing</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Nonpigmented endometriotic lesions compared to the classic pigmented 'powder burns' lesions are more painful</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Degree of pain is directly related to the severity of endometriosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is incorrect regarding the symptomatology of endometriosis?</span></p>",
      "unique_key": "DT1289559",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289559,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>OPTION A:</strong> Depth of penetration is more related to symptoms rather than the spread. <em>Lesions penetrating more than 5 mm are responsible for pain, dysmenorrhea, and dyspareunia.</em></p>\r\n<p><strong>OPTION B:</strong> The symptoms are mostly related to the site of lesion and its ability to respond to hormones. <em>Midline lesions are more symptom producing.</em></p>\r\n<p><strong>OPTION C:</strong> Nonpigmented endometriotic lesions compared to the classic pigmented 'powder burns' lesions produce <em>more prostaglandin F (PGF) and hence are more painful.</em></p>\r\n<p><strong>OPTION D:</strong> The <em>degree of pain experienced by a patient with endometriosis is not necessarily related to the severity or extent of the disease.</em> Some women with minimal or mild endometriosis may experience severe pain, while others with extensive disease may have little to no pain. This variability makes it challenging to predict symptom severity based on the extent of endometriosis alone.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<p>\"7 Ds\" mnemonic for symptoms of endometriosis:</p>\r\n<ol>\r\n<li><strong>Dysmenorrhea</strong>: Painful periods</li>\r\n<li><strong>Dyspareunia</strong>: Pain during sexual intercourse</li>\r\n<li><strong>Dyschezia</strong>: Painful bowel movements</li>\r\n<li><strong>Dysuria</strong>: Painful urination, especially during menstruation</li>\r\n<li><strong>Deep pelvic pain</strong>: Chronic pelvic pain not related to menstruation</li>\r\n<li><strong>Diarrhea or constipation</strong>: Bowel symptoms, especially during menstruation</li>\r\n<li><strong>Difficulty conceiving</strong>: Infertility</li>\r\n</ol>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">CA-125</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">MCP-1</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin 10</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycodelin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Levels of all of the following biomarkers are elevated in a case of endometriosis, except:</span></p>",
      "unique_key": "DT1289560",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Interleukin-10 (IL-10)</strong> levels are typically found to be <strong>decreased</strong>. <em>IL-10 is an anti-inflammatory cytokine</em>, and lower levels of IL-10 are associated with the <em>chronic inflammation seen in endometriosis.</em></p>\r\n<p>OPTION A: <strong>Cancer antigen (CA) 125-a moderate elevation of serum CA 125 is noticed in patients with severe endometriosis</strong>. <em>It is not specific for endometriosis, as it is significantly raised in epithelial ovarian carcinoma.</em> However, it is helpful to assess the therapeutic response and in follow-up of cases and to detect any recurrence after therapy</p>\r\n<p>OPTION B: <strong>Monocyte Chemotactic Protein (MCP-1) level is increased</strong> <em>in the peritoneal fluid of women with endometriosis.</em></p>\r\n<p>OPTION C: OPTION D: <strong>Glycodelin (placental protein 14) is elevated in endometriosis</strong>. <em>Levels also decrease with removal of the disease.</em></p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">It is cystic</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">It is homogenous with low-level internal echoes</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Ground glass echogenicity</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Solid component</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are characteristic features of an endometrioma on a grey-scale USG, except:</span></p>",
      "unique_key": "DT1289561",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>USG features of an endometrioma</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206e97cdebb-6cad-4c2d-8f3a-28e61a555ea4.jpg\">\r\n<p>OPTION A: Typically, an endometrioma appears as a <em>well-defined, unilocular or multilocular cystic lesion.</em></p>\r\n<p>OPTION B &amp; C: Endometrioma often contains <em>low-level internal echoes</em> due to the presence of old blood, which gives it a <em>\"ground-glass\" appearance.</em></p>\r\n<p>OPTION D: Endometrioma <em>usually lacks solid components and papillary projections,</em> which helps differentiate it from malignant ovarian cysts.</p>\r\n<p><strong>KEY TAKEAWAY:</strong> Endometriomas are often referred to as <strong>\"<em>chocolate cysts\"</em></strong> because the old blood inside them resembles chocolate syrup in appearance. This nickname reflects the dark, thick, and old blood found in these cysts, which gives them their characteristic <em>\"ground-glass\" appearance on ultrasound.</em></p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Early menarche</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Short menstrual cycle length</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Pregnancy</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstruction to menstrual flow</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are risk factors for development of endometriosis, except:</span></p>",
      "unique_key": "DT1289562",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Pregnancy <strong><em>has a protective effect</em></strong> that decreases with time (the risk of endometriosis increases with the number of years since last childbirth). <em>Multiple full-term births and prolonged periods of lactation decrease the risk of endometriosis.</em></p>\r\n<p>Early menarche (OPTION A), short menstrual cycle length (OPTION B), and obstruction of menstrual flow (OPTION D) have been associated with increased risk for endometriosis. The correlation between the risk of disease and the volume or duration of menses is less consistent.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206db459275-d3cf-4b24-9329-eb4d8c28f617.jpg\">",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial hyperplasia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenomyosis</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32 year old P3L3 woman with previous 2 LSCS presents with HMB since past 6 months. On clinical examination, her uterus is ~12 weeks size, boggy, mildly tender. USG shows the following appearance. What could be the most likely cause of this clinical presentation?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412067746301d-8f21-48ca-be83-059486603243.jpg\"></span></p>",
      "unique_key": "DT1289614",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>The Venetian blind sign</em> (as shown in the image) is a radiologic sign that can be seen on a pelvic ultrasound and is associated with Adenomyosis (OPTION B). It appears as <em>alternating vertical stripes of hyperechoic and hypoechoic bands,</em> which resemble the horizontal slats of Venetian blinds. The Venetian blind sign is also known as the <em>\"rain shower 2\" appearance.</em></p>\r\n<p>USG features of OPTION A, C &amp; D can be deciphered as per the table shown below.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120609e18e01-a109-4296-ba51-25c9d235bdf0.jpg\">\r\n<p><strong>KEY TAKEAWAY</strong>:</p>\r\n<p><strong>Reference:</strong> www.ncbi.com</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial glands and stroma within the myometrium</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical hyperplasia of the endometrium</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcifications within the myometrium</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Whorled pattern of smooth muscle cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the histopathological hallmark of adenomyosis?</span></p>",
      "unique_key": "DT1289637",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289637,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Adenomyosis is characterized by the presence of ectopic endometrial glands and stroma within the myometrium</strong>, which is the <em>histopathological hallmark of the disease.</em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412068df456c6-71bc-43c3-83cd-7abaa6d6d0a8.jpg\">\r\n<p>OPTION B: <em>Myometrial (&amp; not endometrial) hyperplasia</em> is a feature of Adenomyosis.</p>\r\n<p>OPTION C: If calcifications are observed within the myometrium, it may prompt consideration of other differential diagnoses, such as fibroids or other uterine pathologies, rather than Adenomyosis; like uterine fibroids, chronic endometritis or endometrial carcinoma.</p>\r\n<p>OPTION D: <em>Presence of whorled pattern of smooth muscle cells (watered silk pattern) is characteristic of leiomyoma.</em></p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<p><strong><em>Histological features of Adenomyosis at a glance</em></strong></p>\r\n<p>Ectopic Endometrial Glands</p>\r\n<p>Chronic Inflammatory Infiltrates</p>\r\n<p>Hypertrophy of Myometrium</p>\r\n<p>Myometrial Hyperplasia</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Leiomyoma</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenomyosis</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The MUSA criterion is used in the sonographic assessment of:</span></p>",
      "unique_key": "DT1289646",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289646,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206d934621c-be34-429e-a106-e0bca9888c31.jpg\">\r\n<p>OPTION C: MUSA scoring is used for Adenomyosis (as shown in the above image)</p>\r\n<p>OPTION A: Revised American Society for Reproductive Medicine (ASRM) Classification &amp; EFI scoring is <em>used to assess severity of endometriosis.</em></p>\r\n<p>OPTION B: <em>FIGO Scoring &amp; Lamar classification is used for fibroids</em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120699007c83-deb2-41aa-8cf1-17cc6cf38abe.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412063d8ad79a-5833-443c-aca7-954ec7976d98.jpg\">\r\n<p>OPTION D: <em>WHO Classification is used for Endometrial hyperplasia</em></p>\r\n<p><strong>KEY TAKEAWAY:</strong> MUSA features typical of a uterus with adenomyosis include an enlarged globular uterus, asymmetrical thickening of the myometrium, myometrial cysts, echogenic subendometrial lines and buds, hyperechogenic islands, fan-shaped shadowing, an irregular or interrupted junctional zone and translesional vascularity on color Doppler.</p>\r\n<p><strong>Reference:</strong> https://obgyn.onlinelibrary.wiley.com</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">LNG-IUS</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Continuous oral progestogens</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclical oral progestogens</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Danazol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">First line medical management of endometrial hyperplasia without atypia?</span></p>",
      "unique_key": "DT1289651",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289651,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The LNG-IUS should be the first-line medical treatment <em>because compared with oral progestogens it has a higher disease regression rate with a more favourable bleeding profile</em> and it is associated with fewer adverse effects.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206e45a0426-e7dd-4328-929d-c6dbe46ec2b0.jpg\">\r\n<p><strong>OPTION A: OPTION B:</strong> Continuous progestogens should be used (medroxyprogesterone 10-20 mg/day or norethisterone 10-15 mg/day) <em>for women who decline the LNG-IUS.</em></p>\r\n<p><strong>OPTION C:</strong> Cyclical progestogens should not be used because they are <em>less effective in inducing regression of endometrial hyperplasia</em> without atypia compared with continuous oral progestogens or the LNG-IUS.</p>\r\n<p><strong>OPTION D:</strong> Danazol is a <em>synthetic androgen</em> with a range of uses in Gynecology, including the treatment of endometriosis and certain types of abnormal bleeding. However, its use in endometrial hyperplasia is less common and generally <em>not recommended as a first-line treatment.</em></p>\r\n<p><strong><em>KEY TAKEAWAY:</em></strong></p>\r\n<ul>\r\n<li><strong>LNG-IUS</strong> is preferred due to its <em>effectiveness, better bleeding profile, and fewer side effects.</em></li>\r\n<li><strong>Continuous oral progestogens</strong> are an alternative if LNG-IUS is not acceptable.</li>\r\n<li><strong>Cyclical progestogens</strong> are less effective and are not recommended for endometrial hyperplasia without atypia.</li>\r\n</ul>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Open myomectomy</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">GnRH analogue treatment followed by laparoscopic/open myomectomy</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine artery embolization</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulipristal acetate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 31 year old nulliparous woman, married for 2 years, is complaining of heavy menstrual bleeding. Abdominal examination reveals a 16-week sized uterus. Pelvic examination shows a large interstitial anterior wall fibroid. She is trying to conceive but unable to do so. What is the best management option for this case?</span></p>",
      "unique_key": "DT1289666",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289666,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120698dec82a-6d62-4c34-979c-abb4188e0855.jpg\">\r\n<p>OPTION A: Myomectomy:</p>\r\n<ul>\r\n<li><strong>Description:</strong> Surgical removal of fibroids while preserving the uterus.</li>\r\n<li><strong>Types:</strong>\r\n<ul>\r\n<li><strong>Hysteroscopic Myomectomy:</strong> <em>For submucosal fibroids that are within the uterine cavity</em>. It's performed through the vagina and cervix.</li>\r\n<li><strong>Laparoscopic Myomectomy:</strong> Minimally invasive technique for fibroids <em>located in the uterine wall or outer surface.</em> It involves small incisions and the use of a camera.</li>\r\n<li><strong>Abdominal Myomectomy:</strong> Used for <em>very large fibroids or multiple fibroids.</em> It involves a larger incision in the abdomen.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>OPTION B:</strong> Using a <strong>GnRH (Gonadotropin-Releasing Hormone) analogue</strong> before myomectomy is a common practice aimed at optimizing surgical outcomes.</p>\r\n<p><strong><em><u>GnRH Analogues Before Myomectomy</u></em></strong></p>\r\n<p>Purpose</p>\r\n<ul>\r\n<li><strong><em>Shrink Fibroids:</em></strong> GnRH analogues induce a temporary menopause-like state, which leads to a significant reduction in fibroid size. This makes the fibroids easier to remove and can potentially reduce the complexity of the surgery.</li>\r\n<li><strong><em>Reduce Symptoms:</em></strong> They help manage symptoms such as heavy bleeding and pelvic pain associated with fibroids.</li>\r\n<li><strong><em>Improve Surgical Outcomes:</em></strong> Smaller fibroids and a less vascular uterus can lead to a lower risk of complications, reduced blood loss, and potentially quicker recovery.</li>\r\n</ul>\r\n<h4>Types of GnRH Analogues</h4>\r\n<ul>\r\n<li><strong>Leuprolide:</strong> One of the most commonly used GnRH analogues. It is administered as a daily injection, monthly injection, or a depot injection every 3 months.</li>\r\n<li><strong>Goserelin:</strong> Another GnRH analogue, usually given as a monthly injection or as a depot injection every 3 months.</li>\r\n<li><strong>Triptorelin:</strong> Available in various formulations, including monthly and 3-monthly depot injections.</li>\r\n</ul>\r\n<p>Considerations</p>\r\n<ul>\r\n<li><strong>Temporary Menopause Symptoms:</strong> Patients may experience symptoms similar to menopause, such as hot flashes, vaginal dryness, and mood changes.</li>\r\n<li><strong>Bone Density Loss:</strong> Long-term use can affect bone density. This is usually a concern with prolonged therapy but is less of an issue with short-term use before surgery.</li>\r\n<li><strong>Reversible:</strong> Once the treatment is stopped, normal menstrual function and fertility typically return.</li>\r\n</ul>\r\n<p><strong>OPTION C: Uterine Artery Embolization (UAE)</strong> is a minimally invasive procedure used to manage symptomatic uterine fibroids by blocking the blood supply to the fibroids, causing them to shrink. This procedure is associated with reduced fertility.</p>\r\n<p><strong>OPTION D: Ulipristal Acetate for Managing Large Fibroids</strong></p>\r\n<h4>Mechanism of Action</h4>\r\n<ul>\r\n<li><strong>Action:</strong> Ulipristal acetate works by modulating progesterone receptors, which leads to reduced estrogen stimulation on fibroids. This <em>can decrease fibroid size and control bleeding.</em></li>\r\n</ul>\r\n<p><strong><em>KEY TAKEAWAY:</em></strong></p>\r\n<p><strong><em><u>GnRH analogues before myomectomy</u></em></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206782588a7-728e-4332-b413-44b175e49d8e.jpg\">",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Fractional curettage</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysteroscopy & biopsy</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial aspiration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38 year old woman presents to Gynaec OPD with complaint of heavy menstrual bleeding since past 6 months. Pelvic examination is normal. USG shows focal endometrial thickening. Which out of the following will be the investigation of choice to confirm the diagnosis?</span></p>",
      "unique_key": "DT1289686",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289686,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Reasons for Choosing Hysteroscopy with Endometrial Biopsy (OPTION C):</p>\r\n<ul>\r\n<li><strong>Direct Visualization:</strong> Hysteroscopy allows for direct visualization of the endometrial cavity, which helps to identify abnormalities such as polyps, fibroids, or hyperplasia that might not be fully characterized by ultrasound alone.</li>\r\n<li><strong>Targeted Biopsy</strong></li>\r\n<li><strong>Comprehensive Evaluation:</strong> allows for the immediate treatment of identified lesions if needed (e.g., polypectomy).</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206bf756f65-d417-422e-a46f-953465866143.jpg\">\r\n<p>OPTION A: <strong>Fractional curettage</strong> (D&amp;C) is one of the procedures used to evaluate and manage focal endometrial thickening, but its role and utility depend on the clinical context and the availability of other diagnostic tools. Here's a detailed look at its role in the case of focal endometrial thickening:</p>\r\n<p>Role of Fractional Curettage in Focal Endometrial Thickening: Comparison with Hysteroscopy</p>\r\n<ul>\r\n<li><strong>Visualization:</strong> Unlike hysteroscopy, fractional curettage <em>does not provide direct visualization of the endometrial cavity</em>. Hysteroscopy allows for direct examination and targeted biopsy of abnormal areas.</li>\r\n<li><strong>Procedure:</strong> Fractional curettage involves scraping the endometrial lining with a curette. This can be performed without direct visualization, which may <em>limit the ability to target specific areas of concern.</em></li>\r\n</ul>\r\n<p>OPTION B - MRI is more expensive and less accessible compared to ultrasound. It may not be available in all healthcare settings.</p>\r\n<p><strong>No Direct Sampling:</strong> MRI does not provide tissue samples for histopathological examination. It is used to visualize and assess the anatomy but cannot diagnose specific conditions without biopsy.</p>\r\n<p>OPTION D: <strong>Endometrial Aspiration</strong> is an important diagnostic tool for endometrial thickening. It provides tissue samples for histopathological examination to diagnose various endometrial conditions. While it is a minimally invasive and effective method for obtaining tissue samples, it <em>does not offer direct visualization of the endometrial cavity,</em> which can be complemented by hysteroscopy for a more comprehensive evaluation. Also, there is a <em>risk of incomplete sampling,</em> especially if the <em>focal abnormality is not adequately represented in the aspirated tissue.</em></p>\r\n<p><strong>KEY TAKEAWAY: Hysteroscopy with biopsy</strong> is often considered the gold standard for evaluating endometrial abnormalities, including focal endometrial thickening.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Glanzmann thrombasthenia</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Willebrand disease</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemophilia A</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemophilia B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most common coagulopathy responsible for abnormal uterine bleeding?</span></p>",
      "unique_key": "DT1289738",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289738,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>OPTION B: The most common coagulopathy responsible for abnormal uterine bleeding (AUB) is <strong>von Willebrand disease</strong>.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120694d53e0b-f9e0-4623-98a0-5d9d10c5d191.jpg\">\n<p>OPTION A: Glanzmann disease, though <em>rare</em>, can lead to significant abnormal uterine bleeding due to impaired platelet aggregation. It requires specialized management to control bleeding, especially in women of reproductive age.</p>\n<p>OPTION C: Hemophilia A, while <em>primarily affecting males,</em> can also impact female carriers by causing abnormal uterine bleeding and heavy menstrual bleeding. Management often involves factor VIII replacement therapy and supportive treatments to control bleeding.</p>\n<p>OPTION D: Hemophilia B, although <em>less common than Hemophilia A,</em> can also lead to abnormal uterine bleeding in female carriers. Management typically involves factor IX replacement therapy and supportive treatments to control bleeding, especially during menstruation.</p>\n<p><strong>KEY TAKEAWAY:</strong> Von Willebrand Disease can lead to significant menstrual and abnormal uterine bleeding due to the impaired clotting mechanism. <em>Desmopressin (DDAVP) for vWD Type 1 and some Type 2 patients, replacement therapy with vWF/FVIII concentrates for more severe types, antifibrinolytic agents (e.g., tranexamic acid) for menstrual bleeding.</em></p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Transcervical resection of the endometrium</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Microwave endometrial ablation</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrothermal ablation</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiofrequency endometrial ablation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are second generation endometrial ablation techniques, except:</span></p>",
      "unique_key": "DT1289739",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289739,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241206cba121fd-2d49-4187-a669-b35b4c89cb75.jpg\">\r\n<p>OPTION A: <strong>Transcervical Resection of the Endometrium (TCRE)</strong> is a <em>first-generation endometrial ablation technique</em> used to treat abnormal uterine bleeding. TCRE involves the use of a hysteroscope and a resectoscope loop to surgically remove the endometrial lining of the uterus.</p>\r\n<p>OPTION B: <strong>Microwave Ablation of the Endometrium</strong> is a <em>second-generation endometrial ablation technique</em> that uses microwave energy to treat abnormal uterine bleeding.</p>\r\n<p>OPTION C: <strong>Hydrothermal Ablation</strong>, also known as <strong><em>Thermal Balloon Ablation</em></strong>, <em>is a second-generation endometrial ablation technique</em> that uses heated saline to treat abnormal uterine bleeding.</p>\r\n<p>OPTION D: <strong>Radiofrequency Ablation (RFA)</strong> is a <em>second-generation endometrial ablation technique</em> that uses radiofrequency energy to treat abnormal uterine bleeding. Involves the use of a catheter or device that delivers radiofrequency energy to the endometrial lining, causing <em>controlled thermal destruction of the tissue</em>.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<p>Mnemonic to remember different endometrial ablation techniques:</p>\r\n<p><strong>\"HARMFUL\"</strong></p>\r\n<p>Each letter represents a different technique:</p>\r\n<ul>\r\n<li><strong>H - Hydrothermal Ablation</strong> (Heated saline is used to destroy the endometrial lining)</li>\r\n<li><strong>A - Ablation with Radiofrequency</strong> (e.g., NovaSure; uses radiofrequency energy)</li>\r\n<li><strong>R - Resectoscopic Electrosurgery</strong> (Uses a resectoscope with electrosurgical loop)</li>\r\n<li><strong>M - Microwave Ablation</strong> (Delivers microwave energy to ablate the endometrial lining)</li>\r\n<li><strong>F - Freeze with Cryoablation</strong> (Uses cryoprobe to freeze the endometrial tissue)</li>\r\n<li><strong>U - Uterine Balloon Thermal Ablation</strong> (Thermal balloon filled with heated fluid)</li>\r\n<li><strong>L - Laser Ablation</strong> (Employs laser energy to vaporize the endometrial lining)</li>\r\n</ul>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical cancer</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrophic endometrium</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical polyp</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62 year old postmenopausal woman presents to you with occasional spotting & bleeding since past 3 months. What according to you is the most common cause of post-menopausal bleeding?</span></p>",
      "unique_key": "DT1289740",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289740,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The most common cause of postmenopausal bleeding is <strong>genitourinary atrophy</strong>, accounting for 60%</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412069579a358-5d79-4592-b1ba-ea520a8d96eb.jpg\">\r\n<p>OPTION A: <strong>Cervical Cancer</strong> as a cause of post-menopausal bleeding (PMB) is <em>relatively less common</em> compared to other causes such as endometrial atrophy or hyperplasia. Studies suggest it accounts for about 1-5% of cases of PMB.</p>\r\n<p>OPTION C: <strong>Cervical Polyps</strong> are a relatively common cause of PMB, present in approximately 10-20% of cases.</p>\r\n<p>OPTION D: <strong>Endometrial hyperplasia</strong> accounts for approximately 5-10% of cases of PMB. More common than cervical cancer but less frequent than endometrial atrophy in cases of PMB.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<ul>\r\n<li><em>The most common etiology for postmenopausal bleeding is an atrophic endometrium due to hypoestrogenic state.</em></li>\r\n<li>The collapsed and atrophic endometrial lining within the uterus contains scant or <em>no fluid to prevent friction inside the cavity,</em> causing epithelial microerosions and subsequent chronic inflammation.</li>\r\n<li>Pelvic ultrasounds performed in these patients typically reveal a thin endometrial stripe with an otherwise normal appearance, a small uterus, and small ovaries.</li>\r\n</ul>\r\n<p><strong>Reference:</strong> www.ncbi.com</p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial ablation</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">LNG-IUS</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Combined oral contraceptive pills</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old P4L4 woman presents with a 6-month history of heavy menstrual bleeding. She reports that her last menstrual period was 2 weeks ago and lasted around 10 days with heavy blood flow and passage of blood clots. She has had 4 uncomplicated vaginal deliveries. No complaints of intermenstrual or postcoital bleeding. Transvaginal ultrasound reveals an anteverted uterus of average size, with no evidence of fibroids or polyps, uterine cavity undistorted. She is obese and is a known case of hypertension. What according to you is the most appropriate first-line treatment for this patient's underlying condition?</span></p>",
      "unique_key": "DT1289741",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289741,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>OPTION C: The levonorgestrel intrauterine system (LNG-IUS) can be considered the first-line treatment for heavy menstrual bleeding (HMB) in women with no identified pathology; fibroids less than 3 centimeters in diameter that are not causing uterine cavity distortion; or suspected or diagnosed adenomyosis. In this vignette, LNG-IUS can be considered a first-line treatment as this woman has no identifiable pathology, and transvaginal ultrasound does not detect any polyps or fibroids.</p>\r\n<p>OPTION A: <strong>Hysterectomy</strong> may be considered in the management of abnormal uterine bleeding (AUB) <em>when other treatments have failed or are not appropriate.</em></p>\r\n<p>OPTION B: <strong>Endometrial ablation</strong> is a minimally invasive procedure used to treat abnormal uterine bleeding (AUB) by destroying the lining of the uterus (endometrium). While it can be effective for many women, <em>Following ablation, it may be more challenging to diagnose conditions like endometrial cancer due to scarring of the uterine lining.</em></p>\r\n<p>OPTION D: <strong>COCPs</strong> remain effective in obese women, <em>but higher body weight may reduce the serum levels of contraceptive hormones, slightly increasing the risk of contraceptive failure.</em> <strong>Obesity is an independent risk factor for VTE</strong>. COCPs increase this risk, and the combination can significantly heighten the chance of blood clots. Obesity is associated with higher risks of hypertension, diabetes, and cardiovascular disease. COCPs may exacerbate these risks, particularly in older women or those with additional risk factors (like hypertension in this case).</p>\r\n<p><strong>KEY TAKEWAWAY:</strong></p>\r\n<p>The <em>LNG-IUS releases levonorgestrel locally</em> within the uterus, which <em>reduces endometrial growth,</em> thins the endometrial lining, and <em>decreases menstrual bleeding.</em></p>\r\n<p>The LNG-IUS is highly effective in reducing menstrual bleeding, with many women experiencing a significant decrease in bleeding or even amenorrhea.</p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Isthmocoele</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine A-V Malformation</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Myometrial hypertrophy</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Copper T use</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following conditions come under the category AUB-N, except:</span></p>",
      "unique_key": "DT1289742",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289742,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Bleeding due to a Copper T (CuT) intrauterine device (IUD) falls under the <strong>\"<em>Iatrogenic</em>\" (I)</strong> category of the PALM-COEIN classification system.</p>\r\n<p><strong>Iatrogenic (I)</strong>: This category includes abnormal uterine bleeding (AUB) caused by medical interventions, such as medications, devices (like IUDs), or procedures.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412062d886fc2-980b-4bff-abe3-f0dbb77bc779.jpg\">\r\n<p>In the PALM-COEIN classification system, which is used to categorize causes of abnormal uterine bleeding (AUB), the <strong><em>\"N\" stands for \"Not yet classified\".</em></strong> This category includes conditions that cause AUB but do not fit into the other categories of the PALM-COEIN system.</p>\r\n<p><strong><u>\"N\" Category in PALM-COEIN</u></strong></p>\r\n<ul>\r\n<li><strong>N - Not yet classified</strong>:\r\n<ul>\r\n<li>This category is a placeholder for causes of AUB that are not well understood or do not fit into the other categories.</li>\r\n<li>Examples could include rare conditions or new findings that are still being researched or debated in the medical community.</li>\r\n<li>It includes <em>Uterine A-V Malformation, Myometrial hypertrophy, Isthmocoele and other conditions yet to be elucidated.</em></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>OPTION A: <strong>Isthmocoele</strong> is a term used to describe a niche or defect that occurs at the site of a previous cesarean section scar within the myometrium (muscle layer) of the uterus. This condition can lead to abnormal uterine bleeding (AUB), particularly postmenstrual spotting.</p>\r\n<p><strong>Isthmocoele and AUB</strong></p>\r\n<ul>\r\n<li><strong>Mechanism</strong>: After a cesarean section, incomplete healing of the uterine scar can lead to a small pouch or defect (isthmocoele) where blood and menstrual debris may collect. This can cause prolonged spotting or light bleeding after the end of menstruation, which is considered a form of AUB.</li>\r\n</ul>\r\n<p>OPTION B: <strong>Uterine AVM</strong> can be congenital (present at birth) or acquired due to factors like previous uterine surgeries, curettage, trauma, or pregnancy complications. The abnormal blood vessels create a risk for sudden, severe uterine bleeding.</p>\r\n<p>OPTION C: <strong>Myometrial hypertrophy</strong> can result from chronic stimulation of the uterus, often due to high estrogen levels without progesterone opposition. Women with myometrial hypertrophy may experience AUB characterized by heavy or prolonged menstrual bleeding (menorrhagia) and sometimes intermenstrual bleeding. Some may also report pelvic pain or pressure symptoms.</p>\r\n<p><strong>KEY TAKEAWAY:</strong> Causes of AUB</p>\r\n<ul>\r\n<li><strong>PALM</strong>: Polyps, Adenomyosis, Leiomyoma, Malignancy and Hyperplasia (Structural causes)</li>\r\n<li><strong>COEIN</strong>: Coagulopathy, Ovulatory Dysfunction, Endometrial, Iatrogenic, Not Yet Classified (Non-structural causes)</li>\r\n</ul>\r\n<p><strong>Reference:</strong> FOGSI GCPR on Abnormal Uterine Bleeding</p>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Tranexamic acid</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Combined oral contraceptives</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial ablation</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">LNG-IUS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28 year old woman with a known history of coagulopathy presents with heavy menstrual bleeding. Which of the following treatments is most appropriate for her initial management?</span></p>",
      "unique_key": "DT1289743",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289743,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>OPTION A: The first-line drug for managing abnormal uterine bleeding (AUB) related to coagulopathy is tranexamic acid.</strong></p>\r\n<p><strong>Mechanism of Action:</strong> Tranexamic acid is an <em>antifibrinolytic</em> agent that works by inhibiting the breakdown of fibrin clots, thereby <em>stabilizing blood clots and reducing bleeding.</em></p>\r\n<p><strong>Dosage:</strong> Typically administered as 1-1.5 grams taken orally three to four times a day during menstruation.</p>\r\n<p>OPTION B: <strong>Hormonal COCPs</strong> are considered as <em>2<sup>nd</sup> line drug for management.</em></p>\r\n<p>OPTION C: <strong>Endometrial ablation</strong> is a procedure used to treat abnormal uterine bleeding (AUB) by <em>removing or destroying the endometrial lining of the uterus.</em> In the context of coagulopathy-related bleeding, endometrial ablation requires careful consideration due to the nature of the bleeding disorder.</p>\r\n<p>OPTION D: Any surgical intervention e.g. <strong><em>hysterectomy</em></strong>, <em>may lead to torrential bleed in the setting of a coagulopathy,</em> unless necessary coagulation factor replacement is done. So it is not considered the 1<sup>st</sup> line management option in this case.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120685d683d5-cd1f-4b13-88e4-f282133e7ae2.jpg\">\r\n<p><strong>Reference:</strong> FOGSI GCPR on Abnormal Uterine Bleeding</p>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial carcinoma</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial polyp</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenomyosis</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Leiomyoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman with abnormal uterine bleeding has a history of using tamoxifen for breast cancer. What is the most likely endometrial pathology associated with tamoxifen use?</span></p>",
      "unique_key": "DT1289746",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289746,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Tamoxifen is a <em>nonsteroidal selective estrogen receptor modulator (SERM)</em></strong> that is used primarily for adjuvant treatment of estrogen receptor-positive breast cancer in premenopausal and some postmenopausal patients. It is also <em>used for chemoprevention in selected patients at increased risk for breast cancer.</em></p>\r\n<p>Tamoxifen is associated with an <em>increased risk of uterine pathology.</em></p>\r\n<p>Benign endometrial polyps are the most common type of pathology (OPTION B). Other types of uterine pathology (eg, endometrial hyperplasia and carcinoma (OPTION A), uterine sarcoma, uterine carcinosarcoma) may also occur and the risk depends on many factors, including menopausal status and whether tamoxifen is being used for chemoprevention or treatment of breast cancer.</p>\r\n<p>OPTION C: Adenomyosis &amp; OPTION D: Leiomyoma are relatively less common with tamoxifen use.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<ul>\r\n<li><strong>Risk</strong>: <em>Tamoxifen increases the risk of endometrial polyps</em> due to its estrogenic effects on the endometrium.</li>\r\n<li><strong>Symptoms</strong>: Commonly associated with abnormal uterine bleeding.</li>\r\n<li><strong>Management</strong>: Includes regular monitoring, hysteroscopic removal, and reassessment of tamoxifen use if necessary.</li>\r\n</ul>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}